- |||||||||| oseltamivir / Generic mfg.
Trial completion, Trial primary completion date: A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza (clinicaltrials.gov) - Nov 11, 2015 P1, N=7, Completed, Trial primary completion date: Sep 2015 --> Feb 2016 Active, not recruiting --> Completed | Trial primary completion date: May 2013 --> Jul 2012
- |||||||||| Trial completion: Protecting Pregnant Women From Infectious Diseases (clinicaltrials.gov) - Nov 10, 2015
P=N/A, N=330, Completed, Active, not recruiting --> Completed | Trial primary completion date: May 2013 --> Jul 2012 Active, not recruiting --> Completed
- |||||||||| HibTITER (diphtheria crm197 protein conjugate) / Nuron Biotech, Mitsubishi Tanabe
Trial completion: Exploratory Clinical Study of MT-2301 (clinicaltrials.gov) - Oct 20, 2015 P2, N=157, Completed, Trial primary completion date: Jul 2012 --> Apr 2012 Active, not recruiting --> Completed
- |||||||||| Clinical data, Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada (clinicaltrials.gov) - Oct 20, 2015
P=N/A, N=1849, Completed, Active, not recruiting --> Completed Not yet recruiting --> Completed | N=1280 --> 1849 | Initiation date: Sep 2012 --> Apr 2012 | Trial primary completion date: Feb 2013 --> Sep 2012
- |||||||||| Trial completion, Enrollment change: Brief Influenza Vaccine Education to Pregnant Women (clinicaltrials.gov) - Oct 10, 2015
P=N/A, N=321, Completed, Active, not recruiting --> Completed | N=40 --> 110 Active, not recruiting --> Completed | N=184 --> 321
- |||||||||| Enrollment closed, Trial primary completion date: Text Messaging Reminders for Influenza Vaccine in Primary Care (clinicaltrials.gov) - Oct 7, 2015
P=N/A, N=60, Active, not recruiting, Recruiting --> Active, not recruiting Not yet recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Dec 2015
- |||||||||| Enrollment closed, Enrollment change: Testing the AVI-7100 Flu Drug in Healthy Volunteers (clinicaltrials.gov) - Oct 1, 2015
P1, N=50, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=150 --> 50
- |||||||||| Trial primary completion date: SCID Bu/Flu/ATG Study With T Cell Depletion (clinicaltrials.gov) - Sep 25, 2015
P1/2, N=15, Enrolling by invitation, Active, not recruiting --> Completed Trial primary completion date: Jul 2015 --> Dec 2015
- |||||||||| Fluzone (influenza vaccine) / Sanofi
Enrollment open: Immune and Hormone Response to Influenza Vaccine (clinicaltrials.gov) - Sep 18, 2015 P4, N=100, Recruiting, N=51 --> 0 | Terminated --> Withdrawn Active, not recruiting --> Recruiting
- |||||||||| Trial completion, Enrollment change: Arm Pump in Motorcross Training (clinicaltrials.gov) - Sep 17, 2015
P=N/A, N=11, Completed, Recruiting --> Completed | N=200 --> 74 | Trial primary completion date: Dec 2015 --> Sep 2015 Recruiting --> Completed | N=40 --> 11
- |||||||||| Ampligen (rintatolimod) / AIM ImmunoTech
Trial primary completion date: Safety Study of FluMist With and Without Ampligen (clinicaltrials.gov) - Aug 21, 2015 P1/2, N=72, Recruiting, Trial primary completion date: Apr 2015 --> Apr 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- |||||||||| Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and hemophilus b conjugate) / Sanofi
Trial completion, Enrollment change: Database Surveillance Safety Study of PENTACEL® Vaccine (clinicaltrials.gov) - Aug 20, 2015 P=N/A, N=62538, Completed, Trial primary completion date: Jun 2015 --> Jun 2016 Active, not recruiting --> Completed | N=10000 --> 62538
- |||||||||| Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Phase classification, Enrollment change, Trial primary completion date, Adverse events: IVVE:Pilot: Influenza Vaccine To Prevent Adverse Vascular Events:Pilot (clinicaltrials.gov) - Aug 12, 2015 P4, N=3500, Recruiting, Trial primary completion date: Nov 2015 --> Jul 2017 Phase classification: P2 --> P4 | N=600 --> 3500 | Trial primary completion date: Dec 2015 --> Dec 2019
- |||||||||| Enrollment closed, Trial primary completion date: Micronutrient Supplementation and Incidence of Common Cold (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=82, Active, not recruiting, Phase classification: P2 --> P4 | N=600 --> 3500 | Trial primary completion date: Dec 2015 --> Dec 2019 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Oct 2015
- |||||||||| Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
Enrollment closed, Enrollment change, Trial primary completion date: Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients (clinicaltrials.gov) - Jul 15, 2015 P1, N=51, Active, not recruiting, Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting | N=100 --> 51 | Trial primary completion date: Aug 2015 --> Dec 2015
|